Longitudinal Chest X-ray Scores and their Relations with Clinical Variables and Outcomes in COVID-19 Patients.

This study evaluated the temporal characteristics of lung chest X-ray (CXR) scores in COVID-19 patients during hospitalization and how they relate to other clinical variables and outcomes (alive or dead). This is a retrospective study of COVID-19 patients. CXR scores of disease severity were analyzed for: (i) survivors ( = 224) versus non-survivors ( = 28) in the general floor group, and (ii) survivors ( = 92) versus non-survivors ( = 56) in the invasive mechanical ventilation (IMV) group. Unpaired -tests were used to compare survivors and non-survivors and between time points. Comparison across multiple time points used repeated measures ANOVA and corrected for multiple comparisons. For general-floor patients, non-survivor CXR scores were significantly worse at admission compared to those of survivors ( < 0.05), and non-survivor CXR scores deteriorated at outcome ( < 0.05) whereas survivor CXR scores did not ( > 0.05). For IMV patients, survivor and non-survivor CXR scores were similar at intubation ( > 0.05), and both improved at outcome ( < 0.05), with survivor scores showing greater improvement ( < 0.05). Hospitalization and IMV duration were not different between groups ( > 0.05). CXR scores were significantly correlated with lactate dehydrogenase, respiratory rate, D-dimer, C-reactive protein, procalcitonin, ferritin, SpO2, and lymphocyte count ( < 0.05). Longitudinal CXR scores have the potential to provide prognosis, guide treatment, and monitor disease progression.